Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $3.33 in the prior trading day, Precigen Inc (NASDAQ: PGEN) closed at $3.25, down -2.40%. In other words, the price has decreased by -$2.40 from its previous closing price. On the day, 3.74 million shares were traded. PGEN stock price reached its highest trading level at $3.38 during the session, while it also had its lowest trading level at $3.195.
Ratios:
Our goal is to gain a better understanding of PGEN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 2.71.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 30 ’25 when KINDLER JEFFREY B sold 106,837 shares for $3.38 per share. The transaction valued at 361,109 led to the insider holds 346,070 shares of the business.
KINDLER JEFFREY B sold 67,523 shares of PGEN for $243,083 on Sep 29 ’25. The Director now owns 452,907 shares after completing the transaction at $3.60 per share. On Sep 30 ’25, another insider, KIRK RANDAL J, who serves as the Director of the company, sold 1,809,667 shares for $3.41 each. As a result, the insider received 6,170,964 and left with 14,597,161 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 1146958592 and an Enterprise Value of 944694976. For the stock, the TTM Price-to-Sale (P/S) ratio is 223.14. Its current Enterprise Value per Revenue stands at 217.672 whereas that against EBITDA is -10.284.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.70, which has changed by 2.8235295 over the last 52 weeks, in comparison to a change of 0.17904854 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $5.22, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 0.82%, while the 200-Day Moving Average is calculated to be 70.26%.
Shares Statistics:
The stock has traded on average 8.70M shares per day over the past 3-months and 5368620 shares per day over the last 10 days, according to various share statistics. A total of 297.85M shares are outstanding, with a floating share count of 122.65M. Insiders hold about 60.63% of the company’s shares, while institutions hold 27.55% stake in the company. Shares short for PGEN as of 1757894400 were 35351601 with a Short Ratio of 4.06, compared to 1755216000 on 30907663. Therefore, it implies a Short% of Shares Outstanding of 35351601 and a Short% of Float of 15.52.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.41 and -$0.41 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is $0.06, with 1.0 analysts recommending between $0.06 and $0.06.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $14.38M. There is a high estimate of $15.34M for the next quarter, whereas the lowest estimate is $13.6M.
A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $17.53M, while the lowest revenue estimate was $2.34M, resulting in an average revenue estimate of $13.52M. In the same quarter a year ago, actual revenue was $3.92MBased on 4 analysts’ estimates, the company’s revenue will be $108.91M in the next fiscal year. The high estimate is $158.5M and the low estimate is $64M.
